Approved Study Database

Ref. No. Scientific Title Principal investigator
2011.562 An Open-Label Long-term Safety Extension Trial for Subjects with Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321 (PEARL-SC) Professor Tam Lai-Shan
2011.556 Randomized Evaluative Study of Phenylephrine Or Norepinephrine for maintenance of blood pressure during spinal anaesthesia for caesarean Delivery: The RESPOND study Prof Ngan Kee Warwick
2011.550 Multi-centre, randomised, double-blind and placebo-controlled clinical trial of vitamin D treatment for childhood eczema Prof. Leung Ting Fan
2011.548 A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects With Mild to Moderate Alzheimer Disease Who Are Apolipoprotein E Prof. Vicent MOK
2011.545 Process-oriented exercise programme for the promotion of mental health and physical fitness among people with depression: Randomised controlled trial Prof. Mak Winnie Wing Sze
2011.542 A Long-term Study to Assess the Safety of Fostamatinib in the Treatment of Rheumatoid Arthritis in Asia Professor LI Kwok Ming Edmund
2011.541 A Multi-Centre, Randomised, Double-Blind, Placebo Controlled, Parallel Group Dose Ranging Study in Asia Evaluating Efficacy and Safety of Fostamatinib in Patients with Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate Therapy Professor LI Kwok Ming Edmund
2011.540 A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects With Mild to Moderate Alzheimer Disease Who Are Apolipoprotein E Prof. KWOK Timothy
2011.539 An Open-Label, Multicenter, Follow-Up Study to Evaluate the Long-Term Safety and Efficacy of Brivaracetam Used as Adjunctive Treatment in Subjects Aged 16 Years or Older with Epilepsy Dr. Kwan Patrick
2011.538 An Open-Label, Multicenter Evaluation of the Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor VIII Fusion Protein (rFVIIIFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia A Dr. WONG Raymond Siu Ming
2011.533 Statins and White Matter Lesion Progression: A Randomized, Open-Label, Parallel-Group Study Prof. Mok Vincent Chung Tong
2011.531 The effect of local injury to the endometrium on pregnancy rate for patients undergoing natural-cycle frozen-thawed embryo transfer: a randomized study Dr. KONG Wing Shan
2011.530 Using bipolar technology for transurethral resection of bladder tumor – a randomized controlled trial Dr. CHAN Eddie Shu Yin
2011.529 Effectiveness of warm lignocaine in reducing infiltration pain during digital nerve block injection: A randomized controlled trial. Ms CHAN LAI MAN
2011.528 Chief Project Title: The Role of Interferon Gamma Releasing Assays (IGRA) in Screening and Monitoring for Tuberculosis during Anti-TNF therapy in Patients with Immune-mediated Inflammatory Disease (IMID) Sub-study 1: To evaluate the IGRA status of IBD patients receiving anti-TNF therapy or other immunosuppressive drugs Sub-Study 2: A prospective study of serial interferon-gamma release assays (IGRA) for the diagnosis of tuberculosis (TB) infection in patients with immune-mediated inflammatory diseases (IMID) treated with biologics Sub-Study 3: A retrospective study on the rate of tuberculosis infection in patients treated with biologics Prof. NG Siew Chien
2011.527 Safety & Effectiveness of Nurse Performed Colonoscopies under Supervision: A Randomized Controlled Study in Asia (NE Study) DR HUI ARIC JOSUN
2011.523 A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers Dr. Ho Wing Ming
2011.522 A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Co-Administration of Sitagliptin and Atorvastatin in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin Monotherapy Dr. Risa OZAKI
2011.521 A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Followed by an Open-Label Continuation Period to Assess the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients with Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol Prof. TOMLINSON Brian
2011.520 A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Co-Administration of Sitagliptin and Atorvastatin in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin Monotherapy Dr. Kung Kenny
2011.515 Electroacupuncture for Elder Adults with Mild Cognitive Impairment (MCI): a Randomized Patient and Assessor-Blind Sham-Controlled Trial Prof. LEUNG Albert Wing Nang
2011.510 Comparison of the effect of denosumab and alendronate on bone density and microarchitecture in rheumatoid arthritis females with low bone mass: A randomized controlled trial Prof. Tam Lai Shan
2011.503 Validation of Asia-Pacific Colorectal Screening Score (APCS score) Prof. SUNG Joseph Jao Yiu
2011.501 A quasi-experimental study of a skin care protocol on improving skin hydration and reducing skin tear in geriatric patients Dr. Chan Yue Lai Helen
2011.495 Evaluation of Nitrous Oxide In the Gas Mixture for Anaesthesia: A Randomized Controlled Trial for the Prevention of Chronic Pain After Major Abdominal Surgery Dr. Chan Tak Vai Matthew
2011.489 Providing Repeat Prescription for Patients with Controlled Hypertension – a randomized controlled trial Prof. YIP Benjamin Hon Kei
2011.483 Effect of treat-to-target strategies aiming at remission compared with minimal disease activity on arterial stiffness in early rheumatoid arthritis - a randomized controlled study Prof. TAM Lai Shan
2011.479 An Open-Label, Multicenter Evaluation of the Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX Fusion Protein (rFIXFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia B Dr. WONG Raymond Siu Ming
2011.476 A break time in the colonoscopy session impacts on the quality of colonoscopy: A prospective randomized controlled trial DR HO KAI TIN
2011.475 A brief integrated sleep-focused treatment for persistent sleep disturbances in residual depression: An assessor-blind, parallel group, randomized controlled study Prof. WING Yun Kwok
2011.474 Effect of selective serotonin reuptake inhibitor on satiety function in patients with functional dyspepsia Prof. WU Justin Che Yuen
2011.470 A Phase III, Randomized, Double-blind, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate Compared with Aclidinium Bromide, Formoterol Fumarate and Placebo for 24 Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD) Professor Hui David Shu Cheong
2011.469 A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-914143 in Healthy Chinese Subjects Prof. Brian Tomlinson
2011.468 An Open-Label, Parallel-Group, Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BG00012 in Chinese, Japanese, and Caucasian Adult Healthy Volunteers Professor Tomlinson Brian
2011.467 PROACTYVE pilot: Pilot study of Patient Prof Yeo Winnie
2011.466 Chemoembolization for hepatocellular carcinoma Prof. YU Simon
2011.450 A randomized, controlled clinical trial: The effects of mindfulness-based cognitive therapy on chronic insomnia among Chinese patients in the community Dr. WONG Samuel Yeung Shan
2011.449 A Randomized Controlled Trial of a Specific Narrative Group in Enhancing the Personal Well-being of Stroke Survivors and Caregivers in Hong Kong Dr, Lee Shun Wah Jenny
2011.442 The Application of Transcutaneous Electric Nerve Stimulation on Acupoints (Acu-TENS) for Pain Relief during Colonoscopy: A Prospective, Randomized, Placebo-Controlled Study Prof. Ng Siu Man Simon
2011.437 A Phase IIIb observer-blind, randomized, multicentre primary immunization study to evaluate the immunogenicity and safety of GSK Biologicals’ HPV-16/18 L1 VLP AS04 vaccine and Merck's Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine, when administered intramuscularly according to alternative 2-dose schedules in 9-14 year old healthy females Prof. LEUNG Ting Fan
2011.435 Lifestyle intervention in obese Chinese adolescents with nonalcoholic fatty liver disease: A randomized controlled study Prof. CHAN Dorothy
2011.433 The effect of weight reduction on obstructive sleep apnoea in obese children: a randomized controlled study Professor Nelson Edmund Anthony Severn
2011.432 Consolidation of lifestyle modification for nonalcoholic fatty liver disease by information technology Dr Wong Wai Sun
2011.424 Clinical and Cost Effectiveness of the Nurse Clinic in Emergency Department: A Randomized Controlled Trial Prof. GRAHAM Colin A.
2011.418 A Multicenter, Controlled, Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of Evolocumab (AMG 145) Dr. LUK Andrea On Yan
2011.416 A multicenter, double blind, factorial design, phase IV trial to compare the efficacy and safety of Cilostazol long-term treatment with Aspirin in ischemic stroke patients with high risk of cerebral hemorrhage for the prevention of cerebral hemorrhage and cardiovascular events and to compare the preventive effect of Probucol in the same patient group with non-drug use group for the prevention of cardiovascular events Prof. WONG Lawrence K.S.
2011.400 Pilot study of a systematic and multi-dimensional approach to reduce cardiovascular risk at primary care setting in Hong Kong Professor WEI XIAOLIN
2011.399 Effectiveness of Mind-Body Techniques as an Adjunct Treatment for People with Common Mental Disorders: A Randomized Controlled Trial Dr Leung Maria
2011.397 Prospective Randomized Controlled Trial Comparing Adaptive-support Ventilation with Routine Weaning Protocol after valve Surgery Dr ZHU Fang
2011.396 A Randomized Double Blind Phase 3 Efficacy And Safety Study Of PF-00299804 Versus Erlotinib For The Treatment Of Advanced Non-Small Cell Lung Cancer Following Progression After, Or Intolerance To, At Least One Prior Chemotherapy Prof. MOK Tony

Page 223 of 254.